首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >The use of oxyhaemoglobin to explore the events underlying inhibition of platelet aggregation induced by NO or NO-donors.
【2h】

The use of oxyhaemoglobin to explore the events underlying inhibition of platelet aggregation induced by NO or NO-donors.

机译:氧合血红蛋白的使用探讨了NO或NO供体诱导的血小板聚集抑制的潜在事件。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1. Full inhibition of thrombin-induced platelet aggregation was elicited by the least maximal platelet inhibitory concentrations of nitric oxide (NO; 7 +/- 1 microM) or NO-donors which included sodium nitroprusside (NaNp; 80 +/- 13 microM) 3-morpholinosydnonimine (SIN-1; 3 +/- 0.1 microM) or endothelial cells (EC; 2.36 +/- 0.12 x 10(5) added 1 min before thrombin. Oxyhaemoglobin (oxyHb; 10 microM) administered 30s to 10 min after stimulation with thrombin caused a time-dependent reversal of the inhibition induced by these agents. OxyHb was ineffective when these agents were co-incubated with the non-selective phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX, 0.05 mM). 2. OxyHb did not reverse the platelet inhibition with IBMX (0.2 mM) or that caused by a selective guanosine 3'; 5'-cyclic monophosphate (cyclic GMP) phosphodiesterase inhibitor 2-O-propoxyphenyl-8-azapurin-6-one, (M & B 22948; 20 microM). In addition, oxyHb did not reverse the inhibition with iloprost (1 nM) which inhibits platelet aggregation through stimulation of adenylate cyclase. 3. The inhibition of platelet aggregation by NO (7 +/- 1 microM) or NaNp (80 +/- 13 microM) was accompanied by a 13 fold increase in cyclic GMP levels occurring within 15 s of addition of these agents. In the continued presence of NO or NaNp, the reversing effect of oxyHb given 1 min after thrombin was associated with a pronounced decrease in cyclic GMP levels.(ABSTRACT TRUNCATED AT 250 WORDS)
机译:1.一氧化氮(NO; 7 +/- 1 microM)或包括硝普钠(NaNp; 80 +/- 13 microM)的NO供体的最小血小板抑制浓度达到最小,从而完全抑制了凝血酶诱导的血小板凝集。在凝血酶之前1分钟添加3-morpholinosydnonimine(SIN-1; 3 +/- 0.1 microM)或内皮细胞(EC; 2.36 +/- 0.12 x 10(5))。氧合血红蛋白(oxyHb; 10 microM)在给药后30s至10 min凝血酶刺激可引起这些试剂的时间依赖性逆转。当这些试剂与非选择性磷酸二酯酶抑制剂3-异丁基-1-甲基黄嘌呤(IBMX,0.05 mM)共同孵育时,OxyHb无效2。 OxyHb不能逆转IBMX(0.2 mM)或选择性鸟苷3'; 5'-环一磷酸(环GMP)磷酸二酯酶抑制剂2-O-丙氧基苯基-8-氮杂嘌呤-6-一引起的血小板抑制作用(M &B 22948; 20 microM)。此外,oxyHb不能逆转伊洛前列素(1 nM)的抑制作用通过刺激腺苷酸环化酶抑制血小板聚集。 3. NO(7 +/- 1 microM)或NaNp(80 +/- 13 microM)抑制血小板凝集的同时,循环GMP水平在添加这些试剂的15 s内增加13倍。在持续存在NO或NaNp的情况下,凝血酶1分钟后给予oxyHb的逆转作用与循环GMP水平的显着降低有关(摘要以250字截短)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号